Microfluidics Market: Innovative and Technological Advancement 2022-2031
The flow of liquids through various microscopic channels or
mediums such as nozzles, pumps or chips is based on a technology known as
microfluidics. The products based on such technology can control and direct the
fluids at the lowest dimensions which could range from ten to hundreds of
micrometers.
Microfluidics helps facilitate many assays concurrently.
Thus, increasing the throughput where a good level of spatiotemporal control is
possible. This reduces the consumption and cost of precious fluids, chemical
and biological assays. Numerous applications utilizes microfluidics based
technology such as clinical diagnostics, analytical testing, point-of-care
testing and drug delivery. Genomics, proteomics and cell-based analysis uses
microfluidics technology-based instruments and chips during analytical testing.
List of Key Players Covered in Microfluidics
Market are:
- Thermo
Fisher Scientific Inc
- F.
Hoffmann-La Roche Ltd
- Abbott
Laboratories
- Bio-Rad
Laboratories Inc.
- Qiagen
NV
- SCHOTT
AG
- thinXXS
Microtechnology
Microfluidics systems provides features such as ease of
automation, reduction in the overall consumption of sample and reagents while
reducing the analysis time. Thus, it can be considered as an attractive
solution for various assays like chemical and biological assay. The system also
allows to conduct assays parallel, thus decreasing the cost of the assays and
time.
Microfluidics in 3D cell culture has recently enabled the
development of microenvironments that facilitate differentiation of tissues and
can also replicate the interface between 2 tissues. It can further facilitate
spatiotemporal chemical gradients, as well as mechanical micro - environment of
living organs. There is an ever-increasing demand for microfluidic lab-on-chip
technology in the biomedical, pharmaceutical industries as well in
anti-terrorism, environmental, food and military applications. To further add
to this, the development of consumers, environmental and security markets, the
speed, portability, availability and low costs of miniaturized biosensors have
huge commercial potential.
Strategic collaborations among key players drive the
microfluidics market to develop novel microfluidic platforms for drug
discovery, portable diagnostic devices and others. The collaboration space is
dominated by the players who have a strong product portfolio and patented
technologies dedicated to clinical research and in-vitro diagnostics
applications along with the local GMP certified manufacturing facilities.
In order to overcome difficulties associated with the
fabrication included into the microfluidics devices, many companies are
substituting the mixers in these devices with the bubbles at large. This can be
the opportunity to improve the efficiency of the microfluidics devices creating
a huge opportunity in the market.
Key Takeaways
from Microfluidics Study
- The
ceramics segment is anticipated to hold the maximum share of 39.9% in
2022, expanding at 13.0% CAGR during the forecast period. Ceramics'
superior chemical resistivity, flexibility, and strength make them ideal
for producing microfluidics devices, as seen by their significant market
share.
- The
point of care testing segment is projected to account for 32.6% of the
total market share in 2022 by application. In the fields of genomics and
proteomics, point-of-care testing devices offer a lot of potential. These
devices, for example, aid in the identification of the DNA of bacteria
that cause various diseases and are also employed in protein analysis.
- In-vitro
diagnostics and life science research together hold over 53% of the market
in 2022 and this trend is expected to continue during the forecast period
as well. The growing number of experiment carried out in life science
research using microfluidics is rising. This is propelling the sector
forward. Aside from that, with increasing diseases, is increasing the
in-vitro diagnostics demand.
- North
America is expected to account for about 25.4% of the global microfluidics
market. The high frequency and growth in incidence of various diseases,
and government funding for the research and clinical testing by various
institutions in the North America will assist market expansion.
Who is winning?
The key market players covered by FMI include Thermo Fisher
Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad
Laboratories, Inc., Qiagen NV, SCHOTT AG and thinXXS Microtechnology.
Some of the leading manufacturers of the microfluidics
market are focusing on the development of advanced and cost-effective products
and undertaking acquisitions to increase global presence.
- In
October 2021, Thermo Fisher Scientific Charts Digital PCR expansion after
Combinati acquisition.
- In
November 2019, MicroMedicine, Inc., launched the Sorterra Cell Isolation
System, an automated, microfluidics-based cell isolation technology at the
Society for Immunotherapy of Cancer (SITC) Meeting.
Want more insights?
Future Market Insights brings the comprehensive research
report on forecasted revenue growth at global, regional, and country levels and
provides an analysis of the latest industry trends in each of the sub-segments
from 2016 to 2031. The global microfluidics market is segmented in detail to
cover every aspect of the market and present a complete market intelligence
approach to the reader. The study provides compelling insights on microfluidics
market segment based on material (polymer {polyvinyl chloride (PVC)
non-polyvinyl chloride}, glass, silicon, metal and ceramics), application
(point of care testing, clinical diagnostics, drug delivery and analytical
testing {genomics, proteomics, cell based analysis and others}), and industry
(pharmaceuticals, in-vitro diagnostics, environmental research, life science
research, clinical diagnostics) across seven major regions.
Get
More Details@ https://www.futuremarketinsights.com/reports/microfluidics-market
Comments
Post a Comment